AI’s use in drug discovery is beginning to gain momentum, as seen by the number of large pharmas are already working with smaller AI-based biotechs. Though the term “AI” can carry certain mixed perceptions, scientists within pharma and biotech are starting to realize that AI is poised to make the human element more effective.

The direct and indirect impact of sourcing human biological samples present serious risks for the scientific research community. Through Compli™ -a governance process that provides standardization, transparency and ensures ethical sourcing through one single service- researchers can now mitigate risk and reduce overhead while implementing a formal compliance process.

A few readers of this blog series might recall the thrill of operating the so-called Genetics Computing Group “Wisconsin Package” running on the OpenVMS operating system. Subsequently, its GUI SeqWeb became a precursor to today’s cloud computing concept.

In the first of a series of posts, Tech Snapshot will explore subsets of Data Sciences—life sciences data services, omics analytics and health IT—followed by an overview of three different organizations to assist scientists in furthering their research in this burgeoning area.

At Scientist.com we take cybersecurity, data privacy, client confidentiality and PII very seriously. With a decade of experience building and operating white label and public marketplaces, Scientist.com knows the importance of protecting our clients’ information.